Search for: "Merpel"
Results 221 - 240
of 3,081
Sort by Relevance
|
Sort by Date
4 Apr 2017, 1:55 am
Eleonora Rosati calls for readers’ attention on the new event organised by TIPLO (The Intellectual Property Lawyers Organisation) in London on March 28, 2017.Last but not least, the weekly routines that bring round-ups for the latest IP happenings including events, book release and highlighted blog posts: Never too Late (here ,here and here), Friday Fantasies and Around the IP Blogs (and here) by InternKats Verónica Rodríguez Arguijo, Hayleigh Bosher and Tian… [read post]
31 Mar 2017, 7:35 am
"Perhaps post-Brexit UK laws will be a bit kinder to combo SPCs" muses Merpel. [read post]
30 Mar 2017, 10:19 am
Merpel always expects some slippage, so maybe early 2018 is more realistic for the Court opening. [read post]
26 Mar 2017, 12:48 am
[Merpel is very upset the UK monikers are no longer of the feline persuasion. [read post]
24 Mar 2017, 2:26 am
[Merpel would also like to note that the Katonomist now uses this story in lecturers to demonstrate how digital content is often copied without attribution or incorrectly attributed.] [read post]
23 Mar 2017, 10:00 am
Unless, of course, you are like Merpel and consider time a mere construct... [read post]
21 Mar 2017, 11:45 pm
Regulatory approval, trade secrets and the transatlantic biosimilars patent wars | Biosimilars and generics as "rip-offs": when the facts may not matter | UK's IP Enforcement Framework - IPO Research Bid Opportunity | Curtain - Merpel's final EPO post | Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans | BREAKING: Politico publishes (part of) draft copyright report by MEP Comodini Cachia | Parallel… [read post]
10 Mar 2017, 1:18 am
Merpel hopes that this will continue, and perhaps change will finally come. [read post]
3 Mar 2017, 7:25 am
The High Court has granted declarations to FKB and SB to the effect that their products lacked novelty or an inventive step at a particular date - Fujifilm Kyowa Kirin Biologics Company Limited and Samsung Bioepsis UK Limited v AbbVie Biotechnology Limited [2017] EWHC 395 (Pat). [read post]
1 Mar 2017, 9:08 am
With the ratification of the UPC by the UK government in the face of Brexit, clarification on practical solutions on second medical use patents and developments from the first trade secret litigation in the US, this year’s Forum is not to be missed.The current 25+ speaker line-up features participation from the European Patent Office, IBM, Nokia, DSM, Nissan, Novartis, Qualcomm, PSA Peugeot Citroen, Intel, US Chamber of Commerce, Ericsson, Barclays, BT, BAE Systems and many more.Topics… [read post]
29 Jan 2017, 3:18 am
[Merpel has done a quick check of the USPTO and she found several applications or registrations, none of which however are still valid. [read post]
25 Jan 2017, 10:48 pm
Like AIPPI's final talk of 2016, the AmeriKat is alsobristling - but instead of patent law issues, she is bristling having spotted someone wearing socks with sandalsRight before the Christmas holidays, the UK Group of AIPPI held the annual session devoted to reviewing the year's patent cases. [read post]
25 Jan 2017, 4:15 am
So instead this Kat will record some perhaps peripheral reflections after a day of consideration.The outcome on the main issue was what this Kat expected for the non-legal but very human reason that the Divisional Court decision was unanimously taken by three very senior judges (Merpel - an avid follower of the Order of Precedence - reminds the IPKat that two of them - the Lord Chief Justice and the Master of the Rolls - out-rank all of the Supreme Court judges apart from… [read post]
16 Dec 2016, 4:44 am
| Firings will continue until morale improves - Merpel revisits the EPOPhoto courtesy of Ms. [read post]
15 Dec 2016, 4:27 am
" muses Merpel. [read post]
9 Dec 2016, 1:00 pm
| Firings will continue until morale improves - Merpel revisits the EPONever Too Late 121 [week ending on Sunday 6 November] | Sunday Surprises | Firings will continue until morale improves - Merpel revisits the EPO | Will too much of one and not enough of the other spell bad news for innovation? [read post]
3 Dec 2016, 10:02 am
| Firings will continue until morale improves - Merpel revisits the EPO| Never Too Late 121 [week ending on Sunday 6 November] | Sunday Surprises | Firings will continue until morale improves - Merpel revisits the EPO | Will too much of one and not enough of the other spell bad news for innovation? [read post]
2 Dec 2016, 3:30 am
Alongside the usual analysis of validity and infringement, the case has the attraction of providing guidance on how experts should be cross examined [and more importantly, how they should not be cross-examined, says Merpel]. [read post]
30 Nov 2016, 2:42 am
Thank you Merpel. [read post]
28 Nov 2016, 6:00 am
While acknowledging that in practice, copyright has very little impact on the creative practices of graffiti artists [Merpel muses whether this applies to artists in general], she describes the pros and cons of granting copyright protection to such images. [read post]
